SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027520
Filing Date
2018-11-06
Accepted
2018-11-06 17:16:24
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20180930.htm 10-Q 1607873
2 EX-31.1 acor-ex311_8.htm EX-31.1 16248
3 EX-31.2 acor-ex312_9.htm EX-31.2 15773
4 EX-32.1 acor-ex321_6.htm EX-32.1 6700
5 EX-32.2 acor-ex322_7.htm EX-32.2 6918
  Complete submission text file 0001564590-18-027520.txt   7337713

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acor-20180930.xml EX-101.INS 1927032
7 XBRL TAXONOMY EXTENSION SCHEMA acor-20180930.xsd EX-101.SCH 42017
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20180930_cal.xml EX-101.CAL 55267
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20180930_def.xml EX-101.DEF 148725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20180930_lab.xml EX-101.LAB 356023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20180930_pre.xml EX-101.PRE 287902
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 181163949
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1